Conclusion of non-exclusive drug discount agreements according to § 130a para. 8 SGB V by way of an open-house model for the active ingredient Octreotide (WHO ATC code: H01CB02)

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before May 31, 2028.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.